Rasu Shrestha, Chief Innovation and Commercialization Officer and Executive Vice President at Advocate Health, shared a post by CancerX on LinkedIn, adding:
”If you’re an innovative organization solving for some of the most challenging problems in cancer care, let’s connect at CancerX! The CancerX Accelerator represents a breakthrough solution—a specialized innovation ecosystem connecting startups with leading health systems, payers, and technology enterprises to transform cancer care through digital innovation.
This is how an ecosystem done right, can save lives.
Let’s do this!”
Quoting CancerX‘s post:
”Traction to Impact – why apply to the CancerX Accelerator?
The 2025 CancerX cohort generated 35+ deal opportunities—from pilots and research collaborations to investments and advisory agreements—proving that our multi-champion model drives traction that goes beyond introductions.
Ready to accelerate your company’s impact in oncology? Apply to the CancerX Accelerator today.
Apply to the 2026 CancerX Accelerator.
Discover how strategic partnerships accelerate cancer innovation. Get the insights in our new white paper here.”
More posts featuring Rasu Shrestha on OncoDaily.